PACB

Pacific Biosciences of California Inc
12.245
0.765 (6.66%)
Upgrade to Real-Time
Regular Market
12.245
Volume 4,131,130
Bid Price 12.24
Ask Price 12.25
News -
Day High 12.30

Low
3.85

52 Week Range

High
14.20

Day Low 11.385
Company Name Stock Ticker Symbol Market Type
Pacific Biosciences of California Inc PACB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.765 6.66% 12.245 12:15:04
Open Price Low Price High Price Close Price Prev Close
11.80 11.385 12.30 11.48
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
30,460 4,131,130 $ 11.91 $ 49,203,704 - 3.85 - 14.20
Last Trade Time Type Quantity Stock Price Currency
12:15:04 100 $ 12.245 USD

Period:

Draw Mode:

Pacific Biosciences of California Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.02B 246.23M 197.07M $ 130.51M $ -122.92M -0.91 -8.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -57.97k 2.20%

more financials information »

Pacific Biosciences of C... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PACB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week11.8712.3010.6711.505,089,4050.3753.16%
1 Month8.2312.548.0610.974,924,8284.0248.78%
3 Months9.1612.547.7110.184,283,3623.0933.68%
6 Months4.4414.204.377.966,275,8767.81175.79%
1 Year11.5114.203.857.536,292,5420.7356.39%
3 Years4.6853.692.2014.024,133,5837.57161.65%
5 Years2.8153.692.0212.313,159,4949.44335.77%

Pacific Biosciences of C... Description

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.